Comparison of Rocuronium and Org 25969 With Cisatracurium and Neostigmine (19.4.310)(P05931)

Inclusion Criteria: * Subjects of ASA 1 - 4; * Subjects above or equal to the age of 18; * Scheduled for surgical procedures with a general anesthesia requiring neuromuscular relaxation with the use of rocuronium or cisatracurium; * Scheduled for surgical procedures in supine position; * Given written informed consent. Exclusion Criteria: * Subjects in whom a difficult intubation because of anatomical malformations was expected; * Subjects known or suspected to have neuromuscular disorders impairing neuromuscular block (NMB) and/or significant renal dysfunction; * Subjects known or suspected to have a (family) history of malignant hyperthermia; * Subjects known or suspected to have an allergy to narcotics, muscle relaxants or other medication used during general anesthesia; * Subjects receiving medication in a dose and/or at a time point known to interfere with neuromuscular blocking agents such as antibiotics, anticonvulsants and Mg2+; * Subjects in whom the use of neostigmine and/or glycopyrrolate may be contraindicated; * Subjects who had already participated in an Org25969 trial; * Subjects who had participated in another clinical trial (not pre-approved by NV Organon) within 30 days of entering into CT 19.4.310. * Female subjects who are pregnant: * Female subjects of childbearing potential not using any method of birth control: condom or using only hormonal contraception as birth control; * Female subjects who were breast -feeding.